Abstract
ABSTRACT Purpose: This study was conducted to reveal Türkiye's current situation and make policy recommendations within the scope of the global disease burden 2019 report. Materials and Methods: The data of the study were obtained from the Ministry of Health 2022 health statistics yearbook and IHME 2019 global disease burden report. Within the scope of YLL, YLD, DALY and HALE data, international comparisons were made with age, gender, time, causes and risk factors within the scope of 2002-2019 in Türkiye and policy recommendations were made. Results: Ischemic heart disease, stroke, respiratory tract cancer and diseases are in an upward trend in the disease burden of Türkiye. There have been positive developments regarding maternal and child health. The most important risk factors are; It has been observed that there is tobacco use, high fasting blood sugar and blood pressure, and obesity. Conclusion: Türkiye has indicators at the level of middle-upper income country group in terms of disease burden. Although there are positive developments regarding maternal and child health, Türkiye has an increasing tendency to face a heavy burden of chronic diseases after middle age. This situation indicates that the management of health services becomes more difficult, health expenditures increase and an unhealthy aging society. It is recommended that protective, preventive and health-promoting policies be implemented widely and effectively by balancing the capacity of treatment services.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
